Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yahya Choonara and Girish Modi.
Yahya Choonara
Connection Strength
1,765
Girish Modi
  1. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci. 2010 Jan; 1184:154-72.
    View in: PubMed
    Score: 0,352
  2. Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv. 2016 07; 13(7):1029-43.
    View in: PubMed
    Score: 0,135
  3. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int J Mol Sci. 2009 Jun 03; 10(6):2510-57.
    View in: PubMed
    Score: 0,084
  4. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
    View in: PubMed
    Score: 0,084
  5. Synthesis, Characterisation and In Vitro Permeation, Dissolution and Cytotoxic Evaluation of Ruthenium(II)-Liganded Sulpiride and Amino Alcohol. Sci Rep. 2019 03 11; 9(1):4146.
    View in: PubMed
    Score: 0,042
  6. In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent. Int J Pharm. 2019 Mar 25; 559:255-270.
    View in: PubMed
    Score: 0,041
  7. Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. J Pharm Pharm Sci. 2018; 21(1):94-109.
    View in: PubMed
    Score: 0,038
  8. Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems. Parkinsons Dis. 2017; 2017:7818123.
    View in: PubMed
    Score: 0,036
  9. Development of a Gastric Absorptive, Immediate Responsive, Oral Protein-Loaded Versatile Polymeric Delivery System. AAPS PharmSciTech. 2017 Oct; 18(7):2479-2493.
    View in: PubMed
    Score: 0,036
  10. In Vitro and In Vivo Evaluation of a Hydrogel-Based Microneedle Device for Transdermal Electro-Modulated Analgesia. J Pharm Sci. 2017 04; 106(4):1111-1116.
    View in: PubMed
    Score: 0,036
  11. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov Today. 2016 12; 21(12):1886-1914.
    View in: PubMed
    Score: 0,035
  12. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
    View in: PubMed
    Score: 0,034
  13. Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System. AAPS PharmSciTech. 2017 Apr; 18(3):671-685.
    View in: PubMed
    Score: 0,034
  14. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Int J Pharm. 2016 Mar 16; 500(1-2):196-209.
    View in: PubMed
    Score: 0,033
  15. Ex vivo evaluation of a microneedle array device for transdermal application. Int J Pharm. 2015 Dec 30; 496(2):351-9.
    View in: PubMed
    Score: 0,033
  16. Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
    View in: PubMed
    Score: 0,033
  17. An optimized gastroretentive nanosystem for the delivery of levodopa. Int J Pharm. 2015 Oct 15; 494(1):49-65.
    View in: PubMed
    Score: 0,032
  18. A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive Modulation. AAPS PharmSciTech. 2015 Dec; 16(6):1377-89.
    View in: PubMed
    Score: 0,032
  19. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
    View in: PubMed
    Score: 0,031
  20. Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
    View in: PubMed
    Score: 0,031
  21. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014 Jul 10; 185:130-8.
    View in: PubMed
    Score: 0,030
  22. Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
    View in: PubMed
    Score: 0,029
  23. Cur(Que)min: a neuroactive permutation of curcumin and quercetin for treating spinal cord injury. Med Hypotheses. 2014 Apr; 82(4):437-41.
    View in: PubMed
    Score: 0,029
  24. Patient-controlled analgesia: therapeutic interventions using transdermal electro-activated and electro-modulated drug delivery. J Pharm Sci. 2014 Feb; 103(2):353-66.
    View in: PubMed
    Score: 0,029
  25. An interfacially plasticized electro-responsive hydrogel for transdermal electro-activated and modulated (TEAM) drug delivery. Int J Pharm. 2014 Feb 28; 462(1-2):52-65.
    View in: PubMed
    Score: 0,029
  26. A Hybrid Methacrylate-Sodium Carboxymethylcellulose Interpolyelectrolyte Complex: Rheometry and in Silico Disposition for Controlled Drug Release. Materials (Basel). 2013 Sep 26; 6(10):4284-4308.
    View in: PubMed
    Score: 0,028
  27. A novel pH-sensitive interferon-ß (INF-ß) oral delivery system for application in multiple sclerosis. Int J Pharm. 2013 Nov 18; 456(2):459-72.
    View in: PubMed
    Score: 0,028
  28. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
    View in: PubMed
    Score: 0,028
  29. Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int J Pharm. 2013 May 01; 448(1):267-81.
    View in: PubMed
    Score: 0,027
  30. Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech. 2013 Jun; 14(2):605-19.
    View in: PubMed
    Score: 0,027
  31. Design and pharmaceutical evaluation of a nano-enabled crosslinked multipolymeric scaffold for prolonged intracranial release of Zidovudine. J Pharm Pharm Sci. 2013; 16(3):470-85.
    View in: PubMed
    Score: 0,027
  32. Novel high-viscosity polyacrylamidated chitosan for neural tissue engineering: fabrication of anisotropic neurodurable scaffold via molecular disposition of persulfate-mediated polymer slicing and complexation. Int J Mol Sci. 2012 Oct 29; 13(11):13966-84.
    View in: PubMed
    Score: 0,027
  33. Composite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate. J Drug Deliv. 2012; 2012:579629.
    View in: PubMed
    Score: 0,026
  34. Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with ß-amyloid aggregates of Alzheimer's disease. Pharm Res. 2012 Nov; 29(11):3075-89.
    View in: PubMed
    Score: 0,026
  35. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
    View in: PubMed
    Score: 0,025
  36. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv. 2011; 2011:939851.
    View in: PubMed
    Score: 0,024
  37. In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011 Jan 19; 12(1):694-724.
    View in: PubMed
    Score: 0,024
  38. Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
    View in: PubMed
    Score: 0,024
  39. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,022
  40. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
    View in: PubMed
    Score: 0,021
  41. Computational molecular modeling and structural rationalization for the design of a drug-loaded PLLA/PVA biopolymeric membrane. Biomed Mater. 2009 Feb; 4(1):015014.
    View in: PubMed
    Score: 0,020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.